FDA Inspection 1272491 — QuestSpecialty Corporation

QuestSpecialty Corporation — FEI 3002937340

The FDA completed an inspection of QuestSpecialty Corporation on June 12, 2025 in Brenham, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brenham, TX (United States)

Citations

IDCFRDescription
183321 CFR 211.84(d)(1)Identity Testing of Each Component
900121 CFR 211.22(a)Lack of quality control unit